Sulforaphane in Treating Patients With Recurrent Prostate Cancer

NCT01228084 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

OHSU Knight Cancer Institute

Collaborators